Management of Severe Sepsis in the Surgical Patient

Surgical Clinics of North America

Volumn 86, Issue 6, 2006, Pages 1457-1481

  Sihler, Kristen C ^a   Nathens, Avery B ^b,c  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BENZODIAZEPINE; BICARBONATE; CORTICOSTEROID; DEXMEDETOMIDINE; DIAZEPAM; DOBUTAMINE; DOPAMINE; DROTRECOGIN; FAMOTIDINE; FLUCONAZOLE; FLUDROCORTISONE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; INSULIN; IODINATED CONTRAST MEDIUM; LORAZEPAM; MIDAZOLAM; NORADRENALIN; OMEPRAZOLE; OPIATE; PROPOFOL; PROTON PUMP INHIBITOR; RANITIDINE; SODIUM CHLORIDE; SUCRALFATE; UNINDEXED DRUG; VASOPRESSIN;

ABDOMINAL INFECTION; ACUTE CORONARY SYNDROME; ANALGESIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BACTERIUM CULTURE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CRYSTALLOID; DISEASE EXACERBATION; DRUG HALF LIFE; DRUG MEGADOSE; EARLY INTERVENTION; ENTERIC FEEDING; ERYTHROCYTE TRANSFUSION; FATALITY; FLUID RESUSCITATION; GLUCOSE BLOOD LEVEL; HEART ARREST; HEART MUSCLE ISCHEMIA; HEMOGLOBIN DETERMINATION; HUMAN; HYDRATION; HYPERGLYCEMIA; HYPOTENSION; INCIDENCE; INFECTIOUS COMPLICATION; KIDNEY FAILURE; LONG TERM CARE; LOW DRUG DOSE; METABOLIC ACIDOSIS; MYCOSIS; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; OXYGEN THERAPY; PATIENT MONITORING; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROPHYLAXIS; RESUSCITATION; REVIEW; SEDATION; SEPSIS; STRESS ULCER; SUPERIOR CAVA VEIN; SURGICAL PATIENT; TREATMENT DURATION; TREATMENT WITHDRAWAL; VENTILATOR ASSOCIATED PNEUMONIA;

ANALGESIA; BLOOD TRANSFUSION; CLINICAL PROTOCOLS; CONSCIOUS SEDATION; FLUID THERAPY; GLUCOCORTICOIDS; HUMANS; INFLAMMATION; INTENSIVE CARE; KIDNEY FAILURE, ACUTE; PEPTIC ULCER; PROTEIN C; RESUSCITATION; SEPSIS; SURGICAL PROCEDURES, OPERATIVE; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 33751289693     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.suc.2006.09.005     Document Type: Review

References (94)

1. Levy M.M., Fink M.P., Marshall J.C., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31 (2003) 1250-1256
2. Martin G.S., Mannino D.M., Eaton S., et al. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 (2003) 1546-1554
3. Angus D.C., Linde-Zwirble W.T., Lidicker J., et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29 (2001) 1303-1310
4. Weycker D., Akhras K.S., Edelsberg J., et al. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 31 (2003) 2316-2323
5. Bellomo R., Goldsmith D., Russell S., et al. Postoperative serious adverse events in a teaching hospital: a prospective study. Med J Aust 176 (2002) 216-218
6. Mokart D., Leone M., Sannini A., et al. Predictive perioperative factors for developing severe sepsis after major surgery. Br J Anaesth 95 (2005) 776-781
7. Anaya D.A., and Nathens A.B. Risk factors for severe sepsis in secondary peritonitis. Surg Infect (Larchmt) 4 (2003) 355-362
8. Dellinger R.P., Carlet J.M., Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and shock. Crit Care Med 32 (2004) 858-873
9. Hayes M.A., Timmins A.C., Yau E., et al. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 330 (1994) 1717-1722
10. Gattinoni L., Brazzi L., Pelosi R., et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group. N Engl J Med 333 (1995) 1025-1032
11. Rivers E., Nguyen B., Havstad S., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 35 (2001) 1368-1377
12. Trzeciak S., Dellinger R.P., Abate N.L., et al. Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 129 (2006) 225-232
13. Cochrane Injuries Group Albumen Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 317 (1998) 235-240
14. Wilkes M.M., and Navickis R.J. Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials. Ann Intern Med 135 (2001) 149-164
15. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 350 (2004) 2247-2256
16. Rooke G.A., Schwid H.A., and Shapira Y. The effect of graded hemorrhage and intravascular volume replacement on systolic pressure variation in humans during mechanical and spontaneous ventilation. Anesth Analg 80 (1995) 925-932
17. Michard F., Boussat S., Chemla D., et al. Relation between respiratory changes in arterial pulse pressure and fluid responsiveness in septic patients with acute circulatory failure. Am J Respir Crit Care Med 162 (2000) 134-138
18. Pearse R.M., Ikram K., and Barry J. Equipment review: an appraisal of the LiDCO plus method of measuring cardiac output. Crit Care 8 (2004) 190-195
19. The National Heart. Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Comparison of two fluid management strategies in acute lung injury: the Fluid and Catheter Treatment Trial. N Engl J Med 354 (2006) 2564-2575
20. The National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 354 (2006) 2213-2224
21. Forsythe S.M., and Schmidt G.A. Sodium bicarbonate for the treatment of lactic acidosis. Chest 117 (2000) 260-267
22. Cooper D.J., Walley K.R., Wiggs B.R., et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. A prospective, controlled clinical study. Ann Intern Med 112 (1990) 492-498
23. Graf H., Leach W., and Arieff A.I. Evidence for a detrimental effect of bicarbonate therapy in hypoxic lactic acidosis. Science 227 (1985) 754-756
24. Mathieu D., Neviere R., Billard V., et al. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med 19 (1991) 1352-1356
25. Cariou A., Vinsonneau C., and Dhainaut J.-F. Adjunctive therapies in sepsis: an evidence-based review. Crit Care Med 32 Suppl (2004) S562-S570
26. Ibrahim E.H., Sherman G., Ward S., et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118 (2000) 146-155
27. Iregui M., Ward S., Sherman G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122 (2002) 262-268
28. Montravers P., Gauzit R., Marmuse J.P., et al. Emergence of antibiotic-resistant bacteria in cases of peritonitis after intraabdominal surgery affects the efficacy of empirical antimicrobial therapy. Clin Infect Dis 23 (1996) 486-494
29. Kollef M.H., and Micek S.T. Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen?. Curr Opin Infect Dis 19 (2006) 161-168
30. Rello J., Vidaur L., Sandiumenge A., et al. De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32 (2004) 2183-2190
31. Mort T.C., and Yeston N.S. The relationship of pre mortem diagnoses and post mortem findings in a surgical intensive care unit. Crit Care Med 27 (1999) 299-303
32. Morrell M., Fraser V.J., and Kollef M.H. Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother 49 (2005) 3640-3645
33. Eggimann P., Francioli P., Bille J., et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 27 (1999) 1066-1072
34. Dupont H., Bourichon A., Paugam-Burtz C., et al. Can yeast isolation in peritoneal fluid be predicted in intensive care unit patients with peritonitis?. Crit Care Med 31 (2003) 752-757
35. Golan Y., Wolf M.P., Pauker S.G., et al. Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis. Ann Intern Med 143 (2005) 857-869
36. Chastre J., Wolff M., Fagon J.-Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: A randomized trial. JAMA 290 (2003) 2588-2598
37. Bochud P.-Y., Bonten M., Marchetti O., et al. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med 25 (1997) 1417-1424
38. Marshall J.C., Maier R.V., Jemenez M., et al. Source control in the management of severe sepsis and septic shock: an evidence-based review. Crit Care Med 32 Suppl (2004) S513-S526
39. O'Grady N.P., Barie P., Bartlett J., et al. Practice parameters for evaluating new fever in critically ill adult patients. Crit Care Med 26 (1998) 392-408
40. Cook D., Randolph A., Kernerman P., et al. Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med 25 (1997) 1417-1424
41. Safdar N., and Maki D.G. Inflammation at the insertion site is not predictive of catheter-related bloodstream infection with short-term, noncuffed central venous catheters. Crit Care Med 30 (2002) 2632-2635
42. Mullner M., Urbanek B., Havel C., et al. Vasopressors for shock. Cochrane Database Syst Rev 3 (2004) CD003709
43. Sakr Y., Reinhart K., Vincent J.-L., et al. Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acute Ill Patients (SOAP) study. Crit Care Med 34 (2006) 589-597
44. den Ouden D.T., and Meinders A.E. Vasopressin: physiology and clinical use in patients with vasodilatory shock. Neth J Med 63 (2005) 4-13
45. Homes C.L., Patel B.M., Russell J.A., et al. Physiology of vasopressin relevant to management of septic shock. Chest 120 (2001) 989-1002
46. Dunser M.W., Mayr A.J., Umer H., et al. Arginine vasopressin in advanced vasodilatory shock. A prospective, randomized, controlled study. Circulation 107 (2003) 2313-2319
47. Beale R.J., Hollenberg S.M., Vincent J.-L., et al. Vasopressor and inotropic support in septic shock: an evidence-based review. Crit Care Med 32 Suppl (2004) S455-S465
48. Annane D., Bellissant E., Bollaert P.E., et al. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 329 (2004) 480-488
49. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
50. Annane D., Sébille V., Troché G., et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA 283 (2000) 1038-1045
51. Annane D., Sebille V., Charpentier G., et al. Effect of treatment with low doses of hydrocortisone and fluoricortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-867
52. Bernard G.R., Vincent J.L., Laterre P.F., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344 (2001) 699-709
53. Abraham E., Laterre P.F., Garg R., et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353 (2005) 1332-1341
54. Chohan S.S., McArdle F., McClelland D.B.L., et al. Red cell transfusion practice following the Transfusion Requirements in Critical Care (TRICC) study: prospective observational cohort study in a large UK intensive care unit. Vox Sang 84 (2003) 211-218
55. Walsh T.S., Garrioch M., Maciver C., et al. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion 44 (2004) 1405-1411
56. Vincent J.-L., Baron J.-F., Reinhart K., et al. Anemia and blood transfusion in critically ill patients. JAMA 288 (2002) 1499-1507
57. Scharte M., and Fink M.P. Red blood cell physiology in critical illness. Crit Care Med 31 Suppl (2003) S651-S657
58. Hébert P.C., Wells G., Blajchman M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 340 (1999) 409-417
59. Hébert P.C., Yetisir E., Martin C., et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases?. Crit Care Med 29 (2001) 227-234
60. Wu W.-C., Rathore S.S., Wang Y., et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med 345 (2001) 1230-1236
61. Mazza B.F., Machado F.R., Mazza D.D., et al. Evaluation of blood transfusion effects on mixed venous oxygen saturation and lactate levels in patients with SIRS/sepsis. Clinics 60 (2005) 311-316
62. Corwin H.L., Gettinger A., Pearl R.G., et al. Efficacy of recombinant human erythropoietin in critically ill patients. A randomized controlled trial. JAMA 288 (2002) 2827-2835
63. Rosenzweig M.Q., Bender C.M., Lucke J.P., et al. The decision to prematurely terminate a trial of R-HuEPO due to thrombotic events. J Pain Symptom Manage 27 (2004) 185-190
64. Swart E.L., van Schijndel R.J., van Loenen A.C., et al. Continuous infusion of lorazepam versus midazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med 27 (1999) 1461-1465
65. Peduta V.A., Ballabio M., and Sefanini S. Efficacy of propacetamol in the treatment of postoperative pain: morphine sparing effect in orthopedic surgery. Acta Anaesthesiol Scand 42 (1998) 293-298
66. Kollef M.H., Levy N.T., Ahrens T.S., et al. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest 114 (1998) 541-548
67. Kress J.P., Pohlman A.S., O'Conner M.F., et al. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 324 (2000) 1471-1477
68. Schweickert W.D., Gehlbach B.K., Pohlman A.S., et al. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med 32 (2004) 1272-1276
69. Vender J.S., Szokol J.W., Murphy G.S., et al. Sedation, analgesia, and neuromuscular blockade in sepsis: an evidence-based review. Crit Care Med 34 Suppl (2004) S554-S561
70. Turina M., Fry D.E., and Polk H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 33 (2005) 1624-1633
71. Van den Berghe G., Wouters P.J., Weekers F., et al. Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 31 (2003) 359-366
72. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
73. Schrier R.W., and Wang W. Acute renal failure and sepsis. N Engl J Med 351 (2004) 159-169
74. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients. A multinational, multicenter study. JAMA 294 (2005) 813-818
75. The EPISEPSIS Group. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 30 (2004) 580-588
76. Wan L., Bellomo R., Giantomasso D.D., et al. The pathogenesis of septic acute renal failure. Curr Opin Crit Care 9 (2003) 496-502
77. Bellomo R., Chapman M., Finfer S., et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australia and New Zealand Intensive Care Society Clinical Trials Group. Lancet 356 (2000) 2139-2143
78. De Vriese A.S. Prevention and treatmesnt of acute renal failure in sepsis. J Am Soc Nephrol 14 (2003) 792-805
79. Trivedi H.S., Moore H., Nasr S., et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 93 (2003) C29-C34
80. Mueller C., Buerkle G., Buettner H.J., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 162 (2002) 329-336
81. Liu R., Nair D., Ix J., et al. N-acetylcysteine for the prevention of contrast-induced nephropathy: a systematic review and meta-analysis. J Gen Intern Med 20 (2005) 193-200
82. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 291 (2004) 2328-2334
83. Misset B., Timsit J.F., Chevret S., et al. A randomized cross-over comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure. Intensive Care Med 22 (1996) 742-746
84. Schiffl H., Lang S.M., and Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 346 (2002) 305-310
85. Cook D.J., Fuller H.D., Guyantt G.H., et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med 330 (1994) 377-381
86. Cook D., Guyatt G., Marshall J., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med 338 (1998) 791-797
87. Messori A., Trippoli S., Vaiani M., et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomized controlled trials. BMJ 321 (2000) 1-7
88. Misra U.K., Kalita J., Pandey S., et al. A randomized placebo controlled trial of ranitidine versus sucralfate in patients with spontaneous intracerebral hemorrhage for prevention of gastric hemorrhage. J Neurol Sci 239 (2005) 5-10
89. Kantrova I., Svoboda P., and Scheer P. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology 51 (2004) 757-761
90. Faisy C., Guerot E., Diehl J.L., et al. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med 29 (2003) 1306-1313
91. Granja C., Dias C., Costa-Pereira A., et al. Quality of life of survivors from severe sepsis and septic shock may be similar to that of others who survive critical illness. Crit Care 8 (2004) R91-R98
92. Dowdy D.W., Eid M.P., Sedrakyan A., et al. Quality of life in adult survivors of critical illness: a systematic review of the literature. Intensive Care Med 31 (2005) 611-620
93. Wood K.A., and Ely E.W. What does it mean to be critically ill and elderly?. Curr Opin Crit Care 9 (2003) 316-320
94. Herridge M.S., Cheung A.M., Tansey C.M., et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348 (2003) 683-693